CAH Cardinal Health, Inc.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.…
Industry Peers
Medical DistributionKey Statistics
About Cardinal Health (NYSE: CAH)
›
Cardinal Health (NYSE: CAH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Distribution industry, part of the Healthcare sector, and reports about 58,788 employees.
The shares were at 272.34 USD on 19 November 2026, up 33.3% over 52 weeks. Its 52-week range is 180.45 USD to 286.29 USD: the price is 4.9% below the high and 50.9% above the low.
At a market capitalisation of 62.95B USD, it trades at 35.2 times trailing earnings and 18.9 times forward earnings. The median trailing P/E of its 17 largest Medical Distribution peers is 20.3, a premium of 74% for CAH. It pays a dividend yielding 0.74% (it pays out 27% of its earnings), against a median of 2.55% among the dividend payers in that peer group.
Cardinal Health reports return on equity of -59.5%, an operating margin of 1.3% and revenue up 5.5% year over year.
Its debt exceeds its cash by 3.55B USD. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 15 analysts cover the stock, with an average rating of Buy; their mean price target of 300.80 USD is 10.5% above the current price. The next earnings report is expected on 4 February 2027.